💊 Indications:

Upajak (Upadacitinib 15 mg) is primarily used in the treatment of:

• Moderate to severe rheumatoid arthritis (RA) in patients who have had an inadequate response or intolerance to methotrexate.

• Psoriatic arthritis (PsA)

• Ankylosing spondylitis (AS)

• Other autoimmune conditions as determined by a physician.

It provides an oral, non-biologic alternative to injectable biologic therapies, offering convenience and consistent dosing.

⚙️ Mechanism of Action:

Upadacitinib works by selectively inhibiting JAK1, an enzyme involved in the signaling of various cytokines and growth factors that are crucial in hematopoiesis and immune function. By inhibiting this enzyme, Upajak reduces inflammation, joint pain, and swelling in autoimmune diseases.

📋 Dosage & Administration:

• The recommended dose is one tablet (15 mg) once daily.

• Should be taken at the same time each day, with or without food.

• Swallow whole; do not crush, split, or chew.

⚠️ Precautions & Warnings:

• Contraindicated in patients with known hypersensitivity to Upadacitinib or any component of the formulation.

• Use with caution in patients with chronic infections, liver disease, or risk of thrombosis.

• Regular monitoring of liver function tests, CBC, and lipid profile is recommended.

• Not recommended during pregnancy or breastfeeding without medical advice.

🔬 Quality Assurance:

Manufactured by Everest Pharmaceuticals Ltd., Upajak is produced in facilities that adhere to current Good Manufacturing Practices (cGMP). The formulation is designed for consistent drug release, high efficacy, and excellent patient tolerance.

📦 Distribution Information:

Distributed by: NP Molecule
📍 Address: Sector-14, Uttara, Dhaka-1230, Bangladesh
📞 Phone: +8801844288466
📧 Email: npmolecule23@gmail.com
🌐 Website: www.npmoleculeoncology.com

Two QR codes are provided on the box for easy access to product and prescribing details via mobile scan.

🔖 Tagline Suggestion:

"Upajak – Targeted Relief. Trusted Care."